Dow Up 0.35% Nasdaq Down 0.02%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.42 Up 0.01(0.71%) Aug 20, 4:00PM EDT
Prev Close:1.41
Open:1.42
Bid:1.38 x 10000
Ask:1.47 x 5000
1y Target Est:4.50
Beta:3.59
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.41 - 1.44
52wk Range:1.10 - 2.14
Volume:568,797
Avg Vol (3m):1,816,550
Market Cap:373.29M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXUp 0.71%373.29M
GSKUp 0.97%114.84B
MRKUp 0.97%171.58B
RHHBYDown 0.52%247.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback